As shown in Table 9, a statistically significant difference was observed in the allele frequency of CD40 rs1883832 (T) between lung cancer patients and controls (p=0.021) as well as between the frequencies of the studied genotypes (p=0.003). This evidence concerns the gene CD40 and lung cancer.